Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma

被引:254
作者
Tsai, TJ
Chau, GY [1 ]
Lui, WY
Tsay, SH
King, KL
Loong, CC
Hsia, CY
Wu, CW
机构
[1] Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei 217, Taiwan
[2] Vet Gen Hosp, Dept Pathol, Taipei 217, Taiwan
[3] Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan
关键词
D O I
10.1067/msy.2000.105498
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Tumor venous invasion in patients with resectable hepatocellular carcinoma (HCC) is frequent and can be macroscopic and microscopic or microscopic alone. Although macroscopic invasion is a well-established prognostic indicator the clinical significance of microscopic invasion remains unclear. Methods. There were 322 patients enrolled who had undergone curative resection for HCC. The clinico-pathologic factors and prognostic significance associated with macroscopic and microscopic venous invasion were analyzed. Results. Macroscopic invasion was observed in 50 patients (15.5%) and microscopic invasion in 190 (53.0%). The larger the tumor; the more the incidence of venous invasion. There were 140 patients with microscopic invasion only (Croup I). Patients with macroscopic invasion (Group 2, n = 50) also had microscopic invasion. Compared with patients without venous invasion (Croup 3, n = 132), Group 1 had a higher alpha-fetoprotein level, a larger tumor size, and more tumors without encapsulation. For group 1, the 1-, 3-, and 5-year disease-free survival rates were 65.6%, 41.6%, and 30.8%, respectively. The 1-, 3; and 5-year overall survival rates were 87.8%, 60.0%, and 52.7%, respectively. The survival rates of group 1 were lower than those of group and higher than those of group 2 (P < .05). Multivariate analysis indicated that microscopic and macroscopic venous invasion, surgical margin, indocyanine-green retention, and tumor size anti number were significant predictors of postresectional survival. Conclusions. In HCC patients, microscopic venous invasion is frequent and related independently to postresectional outcome.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 24 条
  • [1] RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA
    ADACHI, E
    MAEDA, T
    MATSUMATA, T
    SHIRABE, K
    KINUKAWA, N
    SUGIMACHI, K
    TSUNEYOSHI, M
    [J]. GASTROENTEROLOGY, 1995, 108 (03) : 768 - 775
  • [2] BOSCH FX, 1997, LIVER CANCER, P13
  • [3] Chau GY, 1997, J SURG ONCOL, V66, P122, DOI 10.1002/(SICI)1096-9098(199710)66:2<122::AID-JSO9>3.3.CO
  • [4] 2-R
  • [5] Rising incidence of hepatocellular carcinoma in the United States
    El-Serag, HB
    Mason, AC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) : 745 - 750
  • [6] Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis - Proposal as a standard therapy
    Ikai, I
    Yamaoka, Y
    Yamamoto, Y
    Ozaki, N
    Sakai, Y
    Satoh, S
    Shinkura, N
    Yamamoto, M
    [J]. ANNALS OF SURGERY, 1998, 227 (03) : 433 - 439
  • [7] RISK-FACTORS LINKED TO TUMOR RECURRENCE OF HUMAN HEPATOCELLULAR-CARCINOMA AFTER HEPATIC RESECTION
    JWO, SC
    CHIU, JH
    CHAU, GY
    LOONG, CC
    LUI, WY
    [J]. HEPATOLOGY, 1992, 16 (06) : 1367 - 1371
  • [8] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [9] Kohli V, 1998, BRIT J SURG, V85, P1171
  • [10] Lee NH, 1998, BRIT J SURG, V85, P1654